QR kód

Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

Cytomegalovirus (CMV) infection in solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients may increase the risk of rejection or allograft dysfunction, other infection(s), and morbidity and mortality. Treatment can be challenging due to medication-associated toxicities. Marib...

Celý popis

Uloženo v:
Hlavní autoři: Lauren Ogawa, Chelsea Morinishi, Ashrit Multani, Pryce Gaynor, Omer E. Beaird, Christine Pham, Joanna M. Schaenman
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2024-12-01
Edice:Viruses
Témata:
CMV
resistance
maribavir
foscarnet
immunocompromised
On-line přístup:https://www.mdpi.com/1999-4915/16/12/1889
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky